DK1964571T3 - Behandling af endothelial dysfunktion hos diabetespatienter - Google Patents

Behandling af endothelial dysfunktion hos diabetespatienter

Info

Publication number
DK1964571T3
DK1964571T3 DK07250870.8T DK07250870T DK1964571T3 DK 1964571 T3 DK1964571 T3 DK 1964571T3 DK 07250870 T DK07250870 T DK 07250870T DK 1964571 T3 DK1964571 T3 DK 1964571T3
Authority
DK
Denmark
Prior art keywords
treatment
endothelial dysfunction
diabetic patients
diabetes induced
patient
Prior art date
Application number
DK07250870.8T
Other languages
English (en)
Inventor
Erik S G Stroes
Original Assignee
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Ltd filed Critical Csl Ltd
Application granted granted Critical
Publication of DK1964571T3 publication Critical patent/DK1964571T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK07250870.8T 2007-03-01 2007-03-01 Behandling af endothelial dysfunktion hos diabetespatienter DK1964571T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07250870A EP1964571B1 (en) 2007-03-01 2007-03-01 Treatment of endothelial dysfunction in diabetic patients

Publications (1)

Publication Number Publication Date
DK1964571T3 true DK1964571T3 (da) 2012-08-13

Family

ID=38124002

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11185508.6T DK2465519T3 (da) 2007-03-01 2007-03-01 Behandling af endotel funktionsforstyrrelse hos diabetespatienter
DK07250870.8T DK1964571T3 (da) 2007-03-01 2007-03-01 Behandling af endothelial dysfunktion hos diabetespatienter

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK11185508.6T DK2465519T3 (da) 2007-03-01 2007-03-01 Behandling af endotel funktionsforstyrrelse hos diabetespatienter

Country Status (5)

Country Link
EP (2) EP1964571B1 (da)
AT (1) ATE555801T1 (da)
DK (2) DK2465519T3 (da)
ES (2) ES2442594T3 (da)
PL (2) PL1964571T3 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4132954A1 (en) * 2020-04-08 2023-02-15 Institut National de la Santé et de la Recherche Médicale (INSERM) Use of cdon inhibitors for the treatment of endothelial dysfunction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239631A4 (en) 1985-10-04 1989-01-12 Biotech Res Partners Ltd RECOMBINANT APOLIPOPROTEINS AND METHODS.
GB8625435D0 (en) 1986-10-23 1986-11-26 Erba Farmitalia Human apolipoprotein ai
IT1229996B (it) 1989-04-20 1991-09-20 Cesare Sirtori Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine.
US5652339A (en) 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
SE9603303D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a protein
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6037323A (en) 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
CA2602946A1 (en) * 2005-03-22 2006-09-28 Medstar Health, Inc. Delivery systems and methods for diagnosing and treating cardiovascular diseases

Also Published As

Publication number Publication date
EP1964571A1 (en) 2008-09-03
HK1171656A1 (en) 2013-04-05
EP2465519A1 (en) 2012-06-20
ES2442594T3 (es) 2014-02-12
PL2465519T3 (pl) 2014-05-30
PL1964571T3 (pl) 2012-10-31
DK2465519T3 (da) 2014-02-03
EP2465519B1 (en) 2013-10-23
EP1964571B1 (en) 2012-05-02
HK1121938A1 (en) 2009-05-08
ES2386905T3 (es) 2012-09-05
ATE555801T1 (de) 2012-05-15

Similar Documents

Publication Publication Date Title
MX2008013304A (es) Compuestos de peptido 1 tipo glucagon.
CY1120054T1 (el) Ετεροκυκλικες ενωσεις για τη θεραπευτικη αντιμετωπιση νευρολογικων και ψυχολογικων διαταραχων
EA202091999A3 (ru) Применение ингибиторов dpp iv
EP2231203A4 (en) SPRAY DEVICE, SYSTEM AND METHOD FOR DISPENSING OXYGEN
DK1808168T3 (da) Kombinationsterapi til behandling af diabetes og tilstande relateret hertil og til behandling af tilstande, der lindres ved at öge et blod-GLP-1-niveau
BRPI0820581A2 (pt) Dispositivo de interface com paciente, e, cânula nasal
DK2068889T3 (da) Anakinra til anvendelse i behandling af bronchiolitis obliterans syndrom
DK2091599T3 (da) Forbedringer af og vedrørende drivmekanismer, der er egnet til anvendelse i anordninger til lægemiddelfremføring
PL2260423T3 (pl) Urządzenie do optymalizacji schematu dawkowania insuliny u pacjenta
EP2303116A4 (en) PATIENT TABLE FOR USE IN MAGNETIC RESONANCE TOMOGRAPHY
DK1881820T3 (da) Engangsdispenser til patientinfusion
DK2019683T4 (da) Indgivelse af vækstfaktorer til behandling af CNS-lidelser
BRPI0919832A8 (pt) inibidores do recptor-3 do fator de crescimento de fibroblasto (fgfr-3) e métodos de tratamento.
EP2134854A4 (en) METHOD OF TREATMENT USING EGFR ANTIBODIES AND CRS INHIBITORS, AND RELATED FORMULATIONS
BRPI0919560A2 (pt) dispositivo para tratamento extracorpóreo do sangue no modo de operação de agulha única e método para a operação de um dispositivo para o tratamento extracorpóreo do sangue
ATE530175T1 (de) Therapeutische kombination für schmerzhafte medizinische zustände
EP2382217A4 (en) NEW INTERMEDIATE PRODUCT AND PROCESS FOR THE PREPARATION OF ENTECAVIR
BRPI0907624A2 (pt) tratamento e prevenção de doenças cardíacas usando duas ou mais isoformas do fator de crescimento de hepatócito
EP1982145A4 (en) ALIGNMENT CORRECTION SYSTEM AND METHODS OF USE
DE602005015378D1 (de) Infusionskatheter für Medikamentenlösung
DK1809318T3 (da) Behandling af korttarmssyndrom-patienter med tyktarmskontinuitet
DK1973541T3 (da) Anvendelse af benzokondenserede heterocykliske sulfamidderivater til nedsættelse af lipid- og blodglucoseniveauer
DE602006000349D1 (de) Medizinisches Instrument mit medizinischer Behandlungselektrode
BRPI0908569A2 (pt) estimuladores de secreção de insulina derivados de piridopirazinonas, métodos para obtê-los e uso dos mesmos para o tratamento de diabetes
UA101961C2 (xx) Кристалічна форма 1 2-((r)-2-метилпіролідин-2-іл)-1h-бензімідазол-4-карбоксаміду$кристаллическая форма 1 2-((r)-2-метилпирролидин-2-ил)-1h-бензимидазол-4-карбоксамида